<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03892408</url>
  </required_header>
  <id_info>
    <org_study_id>1-2019-0005</org_study_id>
    <nct_id>NCT03892408</nct_id>
  </id_info>
  <brief_title>High-flow Nasal Oxygen During Rigid Bronchoscopy Under General Anesthesia: a Randomized Controlled Trial</brief_title>
  <official_title>High-flow Nasal Oxygen During Rigid Bronchoscopy Under General Anesthesia: a Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Yonsei University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Yonsei University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to evaluate the effect of high-flow nasal cannula oxygen
      administration on apnea in patients undergoing general anesthesia with rigid bronchoscopy
      compared with standard anesthesia methods.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 21, 2019</start_date>
  <completion_date type="Anticipated">March 2021</completion_date>
  <primary_completion_date type="Anticipated">March 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>A prospective Randomized, open label Trial</intervention_model_description>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
    <masking_description>triple (Participant, Care Provider, investigator)</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>the lowest oxygen saturation</measure>
    <time_frame>apnea period during the rigidbroscopic procedure/surgery</time_frame>
    <description>the lowest value of oxygen saturation measured percutaneously at extremity.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Hypoxia occurs the first time</measure>
    <time_frame>intraoperative (The time taken to reach the point at which peripheral oxygen saturation fell below 90 for the first time immediately after the onset of apnea)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>End-tidal carbon dioxide partial pressure</measure>
    <time_frame>Intraoperative (end-tidal CO2 partial pressure after 3 consecutive breaths after intubation or insertion of laryngeal mask following end of apnea)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Arterial oxygen / carbon dioxide partial pressure</measure>
    <time_frame>shortly before start of apnea (within 30 seconds)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Arterial oxygen / carbon dioxide partial pressure</measure>
    <time_frame>shortly after end of apnea (within 30 seconds)</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">56</enrollment>
  <condition>Foreign Bodies</condition>
  <condition>Tumor</condition>
  <condition>Stenosis Trachea</condition>
  <condition>Bronchus Tumour</condition>
  <arm_group>
    <arm_group_label>Optiflow</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>100 % of oxygen at 70 L / min through Optiflow ™ (Fisher and Paykel Healthcare Limited, Auckland, New Zealand)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Standard</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>standard anesthesia</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Optiflow ™</intervention_name>
    <description>supply of 100 % of oxygen at 70 L / min through Optiflow ™ (Fisher and Paykel Healthcare Limited, Auckland, New Zealand) plus standard oxygen supply through rigid bronchoscope during apnea period.</description>
    <arm_group_label>Optiflow</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  1. Patients undergoing general anesthesia with stent placement or bougination, biopsy
             or removal of a foreign body or a mass through a rigid bronchoscope

          -  2. Patients aged 19 or older who meet American Society of Anesthesiologists (ASA)
             physical class 2-4

        Exclusion Criteria:

          -  1. Patients with dementia or cognitive impairment

          -  2. pregnant women

          -  3. Patients undergoing extracorporeal membrane oxygenation (ECMO)

          -  4. Patients with active nasal bleeding), severe nasal obstruction, recent nasal trauma
             of surgery

          -  5. Patients with current maxillofacial trauma or basal skull fracture

          -  6. Patients who had previously undergone rigid bronchoscopy / surgery

          -  7. If the subject includes a person who can not read the written consent (eg,
             illiterate, foreigner, etc.)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Department of Anesthesiology and Pain Medicine , Anesthesia and Pain Research Institute, Yonsei University College of Medicine</name>
      <address>
        <city>Seoul</city>
        <zip>120-752</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Young Jun Oh, M.D., PhD.</last_name>
      <phone>82-2-2224-4428</phone>
      <email>yjoh@yuhs.ac</email>
    </contact>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>March 2019</verification_date>
  <study_first_submitted>March 26, 2019</study_first_submitted>
  <study_first_submitted_qc>March 26, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">March 27, 2019</study_first_posted>
  <last_update_submitted>March 28, 2019</last_update_submitted>
  <last_update_submitted_qc>March 28, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">April 1, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Foreign Bodies</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

